Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook 0 02.11.2023 14:07 CNBC Eli Lilly reported revenue and adjusted earnings that topped expectations, lifted by $1.4 billion in sales from its blockbuster diabetes drug Mounjaro. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
